Clincosm LogoSign in Get a demo

Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)

Sponsor
Florida Hospital Tampa Bay Division (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT03739164
Collaborator
(none)
10
Enrollment
1
Location
77.5
Anticipated Duration (Months)
0.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This is a study following the outcomes and survival of patients undergoing the TAMLAPS hepatectomy at Florida Hospital Tampa by Dr. Iswanto Sucandy

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    10 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Complete Robotic Tampa Associating Microwave Liver Ablation With Portal Vein Ligation
    Actual Study Start Date :
    Jul 18, 2018
    Anticipated Primary Completion Date :
    Aug 1, 2024
    Anticipated Study Completion Date :
    Dec 31, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Growth of the Future Liver remnant [2 weeks]

      1. Liver growth determined by measuring the kinetic growth rate obtained from pre-operative and post-op stage one CT evaluations of the FLR volume

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria

    • Patients scheduled to undergo the TAMLAPS procedure by Dr. Iswanto Sucandy.
    Exclusion Criteria:

    • Subjects with history of noncompliance.

    • Subjects with physical health, substance abuse, or mental health problems that will limit the subject's ability to meet study requirements

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Florida Hospital Tampa Tampa Florida United States 33613

    Sponsors and Collaborators

    • Florida Hospital Tampa Bay Division

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Florida Hospital Tampa Bay Division
    ClinicalTrials.gov Identifier:
    NCT03739164
    Other Study ID Numbers:
    • TAMLAPS
    First Posted:
    Nov 13, 2018
    Last Update Posted:
    Nov 13, 2018
    Last Verified:
    Nov 1, 2018
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Cholangiocarcinoma
    Klatskin Tumor

    Study Results

    No Results Posted as of Nov 13, 2018